Clinical characteristics, treatment patterns, and prognosis in vulvar cancer and vaginal cancer: a national multicenter retrospective study in China [PDF]
Background Vulvar and vaginal cancers significantly impact women’s health and quality of life. This study analyzes the prevalence of human papillomavirus (HPV), clinicopathological characteristics, treatment patterns, and survival outcomes, to understand
Xuelian Zhao +16 more
doaj +2 more sources
Treatment patterns and outcomes in perineal primary vulvar cancer-a population-based Swedish cohort study. [PDF]
Perineal vulvar squamous cell carcinoma was identified in 147 of 571 cases. Owing to the anatomical proximity of these tumors to the anus, treatment selection may present considerable clinical challenges. The majority of patients (53%) underwent surgical treatment alone, whereas 23% received surgery combined with adjuvant radiotherapy and 24% were ...
Kjölhede K +4 more
europepmc +2 more sources
Predicting causes of death among vulvar cancer patients; SEER database analysis [PDF]
Background: This study aims to identify causes of death among vulvar cancer patients diagnosed in the period between 2004 and 2013, using the Surveillance, Epidemiology, and End-Results (SEER) Program.
Basel Refky +8 more
doaj +1 more source
Nursing of Vulvar Cancer Radical Operation Combined with Laparoscopic Inguinal Lymph Node Dissection
Purpose. The application, development, and care of radical surgery combined with laparoscopic inguinal lymph node dissection for vulvar cancer. Methods.
Simei Huang, Feifei Qiu
doaj +1 more source
Virus del papil·loma humà com a factor pronòstic en les neoplàsies malignes de la vulva i de la vagina [PDF]
[cat] El Virus del Papil•loma Humà (VPH) està implicat en la patogènesis dels tumors del tracte genital femení i es detecta en la pràctica totalitat dels carcinomes de cèrvix, considerant-se una causa necessària per al seu desenvolupament.
Fusté Chimisana, Maria Victòria
core +6 more sources
There are limited treatment options for patients with advanced vulvar cancer. However, several immune checkpoint inhibitors (ICIs) are FDA-approved or NCCN-Compendia–listed for qualified patients with advanced disease.
Aaron Praiss +5 more
doaj +1 more source
Indocyanine green fluorescent image-guided inguinal sentinel lymph node biopsy in vulvar cancer [PDF]
Objective To demonstrate near-infrared fluorescence image-guided inguinal sentinel lymph node (SLN) biopsy in patients with vulvar cancer. Methods A 40-year-old woman with a 3-cm-sized palpable left vulvar mass was diagnosed with vulvar cancer on biopsy ...
Young Hwa Kwak +6 more
doaj +1 more source
Prevalence of human papillomavirus and its prognostic value in vulvar cancer: A systematic review and meta-analysis. [PDF]
The purpose of this study was to estimate the prevalence of human papillomavirus (HPV) in vulvar cancer and determine whether positive HPV in vulvar cancer was associated with a better prognosis. Literature searches of Ovid EMBASE, PubMed, Web of Science
Jianxin Zhang, Yang Zhang, Zhenyu Zhang
doaj +1 more source
The Society of Gynecologic Oncology (SGO) Journal Club webinar series is an open forum that invites national experts to discuss the literature pertaining to important topics in the management of gynecologic cancers.
Jessica E. Parker +4 more
doaj +1 more source
Summary:. Although primary vulvovaginal reconstruction after vulvectomy has high potential to improve patients’ outcomes, flap reconstruction is not an established part of the current standard treatment for vulvar cancer.
Solji Roh, MD +4 more
doaj +1 more source

